Gerald P Linette

Massachusetts General Hospital

$7,308,810

Attributed

$11,978,167

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY2016–25

$5M$3.8M$2.5M$1.3M$0

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$11,978,167 · 7

By mechanism

R01$2,730,478 · 1

UG3$2,717,473 · 1

UH3$2,238,704 · 1

P01$1,857,735 · 1

U54$1,785,033 · 1

R21$384,965 · 1

Top collaborators

Beatriz M. Carreno8 shared
Carl H. June3 shared

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Marcela Valderrama Maus$16,508,365
Bernard Khor$4,267,406
David E Fisher$28,420,496
Galit Alter$32,273,423
David Kc Cooper$22,744,194

Others in their field

Top investigators on “Peptides”

David M Nathan · Massachusetts Institute Of Technology$118,672,444
John M Lachin · George Washington University$118,672,444
David Heimbrook · Leidos Biomedical Research, Inc.$91,429,616
Michael W Weiner · Northern California Institute Res &Educ$78,425,041
Paul S. Aisen · Cognition Therapeutics, Inc.$69,846,203
Rolf Apweiler · European Molecular Biology Laboratory$56,677,991

Research focus

PeptidesTumorT-LymphocyteTumor AntigensMalignant NeoplasmsMalignant Neoplasm Of LungResponseClinical TrialsPeripheral Blood Mononuclear CellPeripheral BloodEnsureNext Generation SequencingImmunityT Cell ResponseDesignImmuneAntigensPhenotypeMelanomaMissense MutationT Cell TherapyMutateLaboratoriesNeoantigens